-
Even At $500K, Gene Therapy Could Be A Bargain For Some Diseases
Sep 21, 2017, 08:53 AM by Michael CroftMIT Technology Review | A one-time gene therapy that costs half a million dollars sounds crazy until you add up what it costs to treat some diseases over a lifetime.Full story -
ABL acquisition extends Ardena’s early-phase offering
Sep 21, 2017, 05:38 AM by Michael Croft- Sep 21, 2017 - Early-phase contract development and manufacturing organisation (CDMO), Ardena, has acquired bioanalytical contract laboratory, Analytical Biochemical Laboratory (ABL)Full story -
MDI Biological Laboratory Study Finds Immune System Is Critical to Regeneration
Sep 20, 2017, 15:30 PM by Michael CroftBAR HARBOR, ME, UNITED STATES - Sep 20, 2017 - The answer to regenerative medicines most compelling question -- why some organisms can regenerate major body parts such as hearts and limbs while others, such as humans, cannot -- may lie with the bodys innate immune system, according to a new study of heart regeneration in the axolotl, or Mexican salamander, an organism that takes the prize as natures champion of regenerationFull story -
CRISPR Used To Peer Into Human Embryo's First Days
Sep 20, 2017, 13:38 PM by Michael CroftNature News & Comment | Gene-edited embryos enable researchers to unpick role of a crucial gene, with more studies likely to follow.Full story -
Putting Patients First - KCR’s Contribution to Patient-Centric Approach in Clinical Trials
Sep 20, 2017, 06:53 AM by Michael CroftBERLIN, GERMANY - Sep 20, 2017 - Patient-centricity has recently been a key word in the healthcare and drug development industry. KCR, a Contract Research Organization (CRO), is introducing a new project which is solely based on a patient-centric approach: #HumanBehindEveryNumberFull story -
Edico Genome’s DRAGEN Now Available On Illumina’s BaseSpace Sequence Hub
Sep 19, 2017, 11:35 AM by Michael CroftFull storyBio-IT World Brief | Edico Genome today announced the availability of its DRAGEN Bio-IT Platform on Illumina’s BaseSpace Sequence Hub, enabling users to now run DRAGEN instances to enhance the accuracy and speed of their secondary analysis of next-generation sequencing data.
-
HighRes and Titian drive pharma operational efficiency through robotics and inventory logistics
Sep 19, 2017, 08:28 AM by Michael CroftLONDON, UK - Sep 19, 2017 - HighRes and Titian drive pharma operational efficiency through robotics and inventory logisticsTheir combined flexible automation and sample tracking system delivers significant savings by reducing compound management protocols at major pharma companiesxFull story -
Amazon Announces Per-Second Billing For EC2 Instances And EBS Volumes
Sep 18, 2017, 14:00 PM by Michael CroftFull storyAWS Blog | Amazon has announced that, effective October 2, usage of Linux instances that are launched in On-Demand, Reserved, and Spot form will be billed in one-second increments. Similarly, provisioned storage for EBS volumes will be billed in one-second increments. Per-second billing also applies to Amazon EMR and AWS Batch.
-
Cenduit to Discuss Advanced Solutions at Clinical Trial Supply Chain Europe
Sep 18, 2017, 12:06 PM by Michael CroftDURHAM, NC, UNITED STATES - Sep 18, 2017 - WHAT: Cenduit LLC, the largest interactive response technology (IRT) specialist in the world, will be attending the Clinical Trial Supply Chain Europe meeting, September 26 in Zurich, SwitzerlandFull story -
Boris Johnson stresses ‘importance of the life sciences sector to the UK economy’ at TraceLink’s new European HQ launch
Sep 18, 2017, 12:05 PM by Michael CroftUXBRIDGE, UK - Sep 18, 2017 - Foreign Secretary Boris Johnson has officially opened TraceLinks new European headquarters in Uxbridge, UKFull story -
Tjoapack invests in bottle packing capabilities
Sep 18, 2017, 12:00 PM by Michael CroftEARREN-LEUR, NETHERLANDS - Sep 18, 2017 - A Dutch contract packaging organisation (CPO) has strengthened its bottle filling capacity with a major investmentFull story -
Cofactor Genomics announces $18M funding in an oversubscribed Series-A round to bring RNA to Precision Medicine
Sep 18, 2017, 10:26 AM by Michael CroftSAN FRANCISCO, CA, UNITED STATES - Sep 18, 2017 - Cofactor Genomics announces $18M funding in an oversubscribed Series-A round to bring RNA to Precision MedicineSan Francisco, CA - September 18, 2017Cofactor Genomics, developer of a leading platform for RNA sequencing and expression analysis, today announced $18M in financing led by Menlo Ventures with major participation from existing investor Data Collective (DCVC) and new investor Ascension Ventures, and participation from existing and new investors iSelect, Y Combinator, Wilson Sonsini Goodrich & Rosati, and StanfordFull story -
Earlham Institute Presents Sequence Alignment Using Optalysys’ Optical Correlator Computing System
Sep 18, 2017, 09:35 AM by Michael CroftFull storyBio-IT World | 2017 Best Practices Awards | The Earlham Institute are working with Optalysys to apply Optalysys’ optical computing system to life science applications. The first release of the computing system is scheduled for early 2018, which both organizations say will be capable of performing a number of different DNA-based local sequence alignment applications.
-
Demand for genetic testing drives growth for award winning Elucigene diagnostics
Sep 15, 2017, 04:47 AM by Michael CroftMANCHESTER, UNITED KINGDOM - Sep 15, 2017 - Having the right technology at the right time has made Elucigene Diagnostics a world leading developer and distributor of prenatal, rare disease and infertility genetics diagnosticsFull story -
Oxford Genetics Supports Significant Growth with New U.S. Office
Sep 14, 2017, 14:54 PM by Michael CroftBOSTON, MA, UNITED STATES - Sep 12, 2017 - Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has announced that it has opened its first UFull story -
Recipharm and Kancera collaborate to manufacture clinical trial supply
Sep 14, 2017, 14:48 PM by Michael CroftSOLNA, SWEDEN - Sep 14, 2017 - Recipharm, a leading contract development and manufacturing organisation (CDMO) and Kancera, a development company focused on cancer therapy, have signed a contract for the development and manufacture of the pharmaceutical candidate KAND567Full story -
Moderna Ends “Venture” Experiment, Dissolves Four Startups
Sep 14, 2017, 10:03 AM by Michael CroftXconomy | Moderna Therapeutics announced today that it is ending the experiment to hatch startups as wholly-owned subsidaries, bringing all their experimental drugs back into the Moderna nest.Full story -
Kyowa Hakko Kirin Joins Certara’s Simcyp Consortium
Sep 13, 2017, 09:22 AM by Michael CroftPRINCETON, NJ - Sep 13, 2017 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that Kyowa Hakko Kirin CoFull story -
Brainin Joins WuXi NextCODE, Prioritizes Actionability Of Genome
Sep 13, 2017, 09:00 AM by Michael CroftFull storyBio-IT World | WuXi NextCODE today announced the appointment of Rob Brainin as executive vice president and chief operating officer. Brainin joins the company from Illumina, where he was vice president and general manager of life sciences and applied genomics.
-
BC Platforms Launches Unique Global Genomics and Clinical Data Analytics Resource
Sep 13, 2017, 02:12 AM by Michael CroftBASEL, SWITZERLAND - Sep 13, 2017 - BC Platforms, a world leader in genomic data management and analysis solutions, today announces it has launched BC|RQUEST, a unique resource that enables integrated analytics of genomic and clinical dataFull story